tiprankstipranks
Silence Therapeutics Showcases Promising Phase 2 Results
PremiumCompany AnnouncementsSilence Therapeutics Showcases Promising Phase 2 Results
1M ago
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
Premium
The Fly
Silence Therapeutics presents late-breaking Phase 2 zerlasiran data at AHA
1M ago
Silence Therapeutics: Rising Assets Amid Growing Losses
Premium
Company Announcements
Silence Therapeutics: Rising Assets Amid Growing Losses
1M ago
Silence Therapeutics initiated with a Buy at Jefferies
PremiumThe FlySilence Therapeutics initiated with a Buy at Jefferies
4M ago
Silence Therapeutics Reports Increased Losses
Premium
Company Announcements
Silence Therapeutics Reports Increased Losses
4M ago
Seven new option listings and one option delisting on July 10th
Premium
The Fly
Seven new option listings and one option delisting on July 10th
5M ago
Silence Therapeutics Secures $2M Milestone Payment
PremiumCompany AnnouncementsSilence Therapeutics Secures $2M Milestone Payment
6M ago
Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
Premium
The Fly
Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
6M ago
Silence Therapeutics’ Zerlasiran Shows Promising Results
Premium
Company Announcements
Silence Therapeutics’ Zerlasiran Shows Promising Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100